Retatrutide: What the peptide is and how it works

Retatrutide is one of the most talked-about new peptides in research on weight loss and metabolism. Unlike older GLP-1 peptides, it acts on three different receptors at once, making it one of the most studied substances in its category right now. Here we go through what Retatrutide is and what research has shown so far.

What is Retatrutide?

Retatrutide is a synthetic peptide belonging to the group of incretin mimetics – substances that mimic the body's own incretin hormones. What sets Retatrutide apart from many other peptides in the same category is that it's a so-called triple agonist: it activates three different receptors simultaneously instead of one or two.

How does Retatrutide work in research?

In preclinical and clinical studies, Retatrutide has been examined for its simultaneous effect on three receptor systems:

• The GLP-1 receptor – linked to satiety and blood sugar regulation
• The GIP receptor – involved in insulin release and fat metabolism
• The glucagon receptor – associated with increased energy expenditure

By combining all three mechanisms of action in the same molecule, Retatrutide is studied to see whether the effect on body weight and metabolism becomes more pronounced than with peptides that only affect one or two of these receptors. As with all research at this stage, results are study-specific and should be interpreted in their scientific context.

Common administration methods

In research settings, Retatrutide is usually administered via subcutaneous injection. The peptide is supplied as a freeze-dried powder and must be reconstituted with bacteriostatic water before it can be used in a research protocol. An insulin syringe with a fine needle is usually used for precise dosing during injection.

Dosing in research contexts

Dosing ranges that appear in published research vary considerably depending on study design. Since Retatrutide is sold by us as a product intended for laboratory and research purposes – not for human consumption – we don't provide a specific dosing recommendation here. Always refer to the research protocol and scientific literature relevant to your specific purpose.

Retatrutide compared to other GLP-1 peptides

Several peptides in the same research field, such as semaglutide and tirzepatide, act on one and two of the receptors above, respectively. Retatrutide's triple action makes it one of the most interesting points of comparison in current research on incretin-based mechanisms, since it allows the effect of all three receptor systems to be studied in combination.

Quality and purity

Since peptides are sensitive molecules, purity and correct handling are crucial for reliable research results. Our Retatrutide is tested by an independent third-party laboratory, and we publish a certificate of analysis (COA) for every batch.

Want to read more about dosing, storage and reconstitution of peptides in general? Our peptide guide covers it step by step.

Summary

Retatrutide is a research peptide that, through its triple-agonist action on the GLP-1, GIP and glucagon receptors, is one of the most studied substances in metabolism and body-weight research right now. As with all peptides, purity, correct storage and careful handling are crucial for reliable research results.

Ready to get started? Explore our lab-tested Retatrutide 10mg with free shipping over 899 kr, or see our full range in the Weight Loss category.